Establishing normal reference ranges for PSA change with age in a population-based study: The Krimpen study.
BACKGROUND
We aim to establish the normal pattern of prostate specific antigen (PSA) change with age to provide a baseline from which disease progression might be identified in prostate cancer patients included in active surveillance programs.


METHODS
In a community-based study, PSA values were determined at baseline and after 2.1 and 4.2 years in men without prostate cancer. A bivariate multilevel growth curve model was used to estimate the pattern of change of PSA with age.


RESULTS
The final model showed that PSA was related to age only. The future PSA of an individual can be predicted based on his age and known history of PSA. The model was also used to calculate PSA doubling time for men with different PSA values at different ages.


CONCLUSIONS
This method establishes normal PSA levels by age using PSA history in men without prostate cancer. The model provides baseline data from which disease progression might be detected.
Bosch
J L H R
JL
Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands. j.l.h.r.bosch@umcutrecht.nl
Tilling
K
K
Bohnen
A M
AM
Donovan
J L
JL
D000367:Age Factors; D000368:Aged; D018450:Disease Progression; D006801:Humans; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D011446:Prospective Studies; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000473:pathology*; D012016:Reference Values
D017430:Prostate-Specific Antigen